About 317,000 results
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
Ebglyss Approved for Moderate to Severe Atopic Dermatitis
Pediatric Atopic Dermatitis: Dupilumab Normalizes Inflammatory …
UNION therapeutics to present orismilast Phase 2b results in atopic ...
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and ...
Aclaris doses first subject in Phase IIa atopic dermatitis trial
Atopic dermatitis - Latest research and news | Nature
New Treatment for Moderate to Severe Atopic Dermatitis Shows …
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Atopic dermatitis: an expanding therapeutic pipeline for a …